NeuroMetrix, Inc.
NURO
$4.34
-$0.035-0.80%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -19.55% | -37.75% | -46.70% | -58.67% | -47.83% |
Total Depreciation and Amortization | 32.31% | 165.93% | 111.02% | 308.57% | 256.48% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -147.81% | -112.29% | -103.89% | -73.63% | -66.76% |
Change in Net Operating Assets | 9,905.26% | 154.97% | 143.00% | 133.59% | 100.33% |
Cash from Operations | -17.15% | -9.34% | -10.74% | -24.24% | -15.04% |
Capital Expenditure | -- | 67.15% | -1,773.47% | -931.46% | -691.38% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 299.13% | -6.96% | 923.93% | 113.14% | 107.98% |
Cash from Investing | 362.46% | -4.36% | 867.64% | 112.08% | 106.88% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -36.51% | 18.47% | 18.59% | 97.63% | -39.82% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -36.51% | 18.47% | 18.59% | 97.63% | -39.82% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 88.31% | -73.07% | 93.82% | 94.78% | 85.73% |